Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy.
Blood. 2022 Apr 7;139(14):2156-2172. doi: 10.1182/blood.2021012714.
Blood. 2022.
PMID: 34861037